التفاصيل البيبلوغرافية
| العنوان: |
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial |
| المؤلفون: |
Janjigian, Yelena Y, Maron, Steven B, Chatila, Walid K, Millang, Brittanie, Chavan, Shweta S, Alterman, Carly, Chou, Joanne F, Segal, Michal F, Simmons, Marc Z, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y, Zervoudakis, Alice, Won, Elizabeth S, Kelsen, David P, Ilson, David H, Nagy, Rebecca J, Lanman, Richard B, Ptashkin, Ryan N, Donoghue, Mark T A, Capanu, Marinela, Taylor, Barry S, Solit, David B, Schultz, Nikolaus, Hechtman, Jaclyn F |
| المصدر: |
The Lancet Oncology ; volume 21, issue 6, page 821-831 ; ISSN 1470-2045 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2020 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/s1470-2045(20)30169-8 |
| الإتاحة: |
https://doi.org/10.1016/s1470-2045Test(20)30169-8
https://api.elsevier.com/content/article/PII:S1470204520301698?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1470204520301698?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
| رقم الانضمام: |
edsbas.6F2409AE |
| قاعدة البيانات: |
BASE |
